Results 11 to 20 of about 1,030 (166)
Медицинский совет, 2021 This article provides an overview of current views on the problem of allergic rhinitis (AR) in children. Modern data on the epidemiology of AR and the main comorbid conditions are highlighted.
E. P. Karpova, D. A. Tulupov
doaj +1 more source
Is the use of intranasal glucocorticosteroids (inGCSs) in children safe?
Otolaryngologia Polska, 2015 It's been 40 years since Niels Mygind publication in British Medical Journal on intranasal application of beclomethasonedipropionate aerosol in Allergic Rhinitis. Since then the new era in treatment of allergic and non-allergic upper airway diseases has begun.
Anna, Nowicka, Bolesław, Samoliński
openaire +3 more sources
Pharmacotherapy of allergic rhinitis
Медицинский совет, 2020 The clinical picture of allergic rhinitis includes sneezing, nasal discharge, impaired nasal breathing, and itching of the nose and roof of mouth. Depending on the duration of symptoms, allergic rhinitis is divided into intermittent and persistent forms,
V. T. Pal’chun +3 more
doaj +1 more source
Allergic rhinitis from the otorhinolaryngologist’s perspective
Медицинский совет, 2021 Allergic rhinitis remains one of the most pressing problems of modern otorhinolaryngology. Allergic rhinitis is an allergic inflammation of the nasal mucosa characterised by the following symptoms (one or more): stuffiness, rhinorrhoea, nasal itching ...
J. M. Mustafaev
doaj +1 more source
New opportunities in the allergic rhinitis therapy
Медицинский совет, 2021 Allergic rhinitis (AR) is one of the most common allergic diseases, especially in economically developed countries, including Russia. The main goal of AR therapy is the control achievement over the disease symptoms, the minimizing of the future ...
K. S. Pavlova, D. S. Mdinaradze
doaj +1 more source
Otolaryngologia Polska, 2014 It has been 40 years since Niels Mygind's publication in British Medical Journal on intranasal application of beclomethasone dipropionate aerosol in allergic rhinitis (AR). Since then a new era in treatment of allergic and nonallergic upper airway diseases began.
Bolesław, Samoliński +5 more
openaire +2 more sources
Biologics for the treatment of chronic rhinosinusitis with nasal polyps : state of the art [PDF]
, 2019 Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex upper airway disease affecting up to 11% of the population of Western Europe. In these western countries, 85% of the CRSwNP disease reveals a type 2 inflammatory pattern. In the last 15 years,
Bachert, Claus +3 more
core +1 more source
Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group
Медицинский совет, 2018 Recent studies show that perennial allergic rhinitis is prevalent among older people, but the management of this disease is underestimated and not determined.
K. I. Sapova, S. V. Ryazantsev
doaj +1 more source
Drug therapy of allergic rhinitis in children
Медицинский совет, 2013 The article tells about modern approaches to drug therapy of allergic rhinitis in children. Based on published research data, the authors define the role of modern intranasal glucocorticosteroids in the treatment of allergic rhinitis and comorbid ...
E. P. Karpova, D. A. Tulupov
doaj +1 more source
Basic principles for the treatment of chronic rhinosinusitis with nasal polyps
Медицинский совет, 2020 Introduction. Chronic rhinosinusitis with nasal polyps (CRSwNP) is based on a chronic inflammatory hyperplastic process in the mucosa membrane of the nasal cavity and paranasal sinuses (SNPs).
E. L. Savlevich +2 more
doaj +1 more source